Navigation Links
Sinovac Schedules 2008 Annual General Meeting
Date:6/10/2009

BEIJING, June 10 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, announced today that it will hold its 2008 Annual General Meeting on Thursday, July 16, 2009 at 9:00 a.m. Beijing Time. The meeting will be held concurrently at No. 39 Shangdi Xi Road, Haidian District, Beijing, PRC and at No. 6 Temple Street, St. John's, Antigua. All shareholders of record as of May 27, 2009 will be eligible to vote and are invited to attend. Sinovac 2008 annual report and the proxy statements are also be available at the company's website: http://www.sinovac.com/Investors/SECFilings/ and http://www.sinovac.com/Investors/IRHome/presentation/ .

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). Panflu(TM), Sinovac's pandemic influenza vaccine (H5N1), has already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis vaccine, and human rabies vaccine. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
2. Sinovac Provides Support to Chinas Ministry of Health to Aid Earthquake Victims
3. Sinovac Announces that Government Investigation Rules Out Healives Role in Childs Death
4. Sinovac Reports Unaudited First Quarter 2009 Financial Results
5. Roper Industries Schedules Third Quarter 2007 Financial Results Conference Call
6. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
7. Immucor Schedules First Quarter Earnings Release and Conference Call
8. Omnicell Schedules Third Quarter Earnings Call
9. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
10. AMICAS Schedules Third Quarter Earnings Call
11. Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... Dr. Lawrence ... Washington, DC, area patients. Kybella is a non-surgical method to dissolve fat ... of reducing moderate to severe fat deposits under the chin, commonly known as a ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The ... Hospital in Newport News, VA. The procedure was an L5-S1 posterior lumbar interbody ...
(Date:7/6/2015)... ... ... Thanks to donations and a generous grant from the GAR Foundation, Senior ... patients and adult day center participants. , The Music & Memory program is committed ... families and volunteers. Music & Memory is a non-profit organization that helps provide patients ...
(Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... ... ancillary benefits market, is excited to announce the next generation of PrimeStar Individual ... Advantage plans to now include two network options—Maximum Allowable Charge (MAC) and usual, ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women's Excellence in ... in Lake Orion. These classes are geared towards families that want their children ... break. , The fitness class will take place TUESDAYS at 4:30pm. Questions? ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... scientists have found that chemicals used to line junk ... food and being ingested by people where they are ... Perfluorinated carboxylic acids or PFCAs are the breakdown products ... stain-repellant products ranging from kitchen pans to clothing to ...
... Nov. 8, 2010 A small amount of bleeding ... individuals, according to a UC Irvine study. Neurologist ... that cerebral microbleeds are highly prevalent in the aging ... hypertension or neurodegenerative diseases such as Alzheimer,s, as had ...
... , MONDAY, Nov. 8 (HealthDay News) -- Because ... bone loss, long missions may take a toll on crew ... lead investigator Dr. Shreyasee Amin, an associate professor at the ... in 28 U.S. space crew members (24 males, four females) ...
... to have joint pain from taking aromatase inhibitors (AIs) if ... at the American College of Rheumatology,s annual meeting, held Nov. ... to identify factors that increase the likelihood that a patient ... standard adjuvant therapy for post-menopausal breast cancer, can cause joint ...
... International experts and scientists will present new ... of stockpiled drugs to identifying unlabeled substances in ... the 2010 International Pharmaceutical Federation (FIP) Pharmaceutical Sciences ... Association of Pharmaceutical Scientists (AAPS) Annual Meeting and ...
... Substandard and counterfeit versions of thirteen key antimalarial medicines ... Medicines Quality Monitoring surveillance program. Set up by the ... the U.S. Pharmacopeial Convention (USP) and the U.S. Agency ... the public and private sectors. It was established in ...
Cached Medicine News:Health News:Dangerous chemicals in food wrappers likely migrating to humans: U of T study 2Health News:Spending Months in Space May Cause Long-Term Bone Loss 2Health News:Study sheds light on aromatase inhibitor joint pain syndrome 2Health News:Study sheds light on aromatase inhibitor joint pain syndrome 3Health News:Substandard and counterfeit antimalarial drugs discovered in Ghana 2
(Date:7/3/2015)... July 3, 2015 A global ... hypertension, diabetes and thyroid disorders in Latin ... a major conference dedicated to these diseases. ... Online , Manage Hypertension Online and ... by EXCEMED - combine the world,s top ...
(Date:7/3/2015)...  Obsidian HDS, the developer of PharmaShine ( ... management of data on pharmaceutical and device industry payments ... the 2014 Open Payments General and Research data released ... The data disclosed on Open Payments for 2014 includes ... totaling $6.49 billion and is the largest public disclosure ...
(Date:7/2/2015)... Pharma Major Lupin Limited ... en ZAO "Biocom" en Rusia bajo ciertas condiciones ... Lupin en el mercado farmacéutico de Rusia que ... como uno de los 10 principales mercados farmacéuticos ... de una década, el mercado farmacéutico ruso registró ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... N.J., Jan. 3, 2011 The U.S. Food and ... to include a 200 mg formulation of INTELENCE ® ... for the treatment of human immunodeficiency virus (HIV-1) in ... antiretroviral (ARV) agents.   The recommended oral ...
... 2011 Henry Schein, Inc. (Nasdaq: HSIC ... services to office-based practitioners, today announced it has completed ... closing conditions have been met, including approval of the ... Provet Holdings is Australasia,s largest wholesale distributor of ...
Cached Medicine Technology:FDA Approves New Dosage Strength for INTELENCE® 2FDA Approves New Dosage Strength for INTELENCE® 3FDA Approves New Dosage Strength for INTELENCE® 4FDA Approves New Dosage Strength for INTELENCE® 5Henry Schein Completes Acquisition of Provet Holdings Limited 2Henry Schein Completes Acquisition of Provet Holdings Limited 3Henry Schein Completes Acquisition of Provet Holdings Limited 4
... monomeric contrast medium for intravascular and body ... a decade of clinical experience and use ... proven to be a valuable part of ... departments.Results from large multicentre monitoring trials1-3 confirm ...
... MultiHance (gadobenate dimeglumine) is a paramagnetic ... is complexed with gadobenate, a chelating agent ... around the godolinium ion. It is salified ... is endowed with all the physico-chemical features ...
... U.S. in 1993 to provide contrast enhancement ... detect lesions of the brain, spinal cord, ... approval for adult body and high-dose CNS ... OMNISCAN comes in different sizes to accommodate ...
... When MAGNEVIST (gadopentetate dimeglumine) injection was ... revolutionary concept of contrast-enhanced magnetic resonance imaging ... agent for use in MRI. Today, the ... indications in CNS, head, neck and body. ...
Medicine Products: